Vaisala Group
Vaisala Corporation: Managers’ Transactions – Castrén, Petri
Vaisala Corporation: Managers’ Transactions – Castrén, Petri
Vaisala Corporation
Managers’ Transactions
February 21, 2025, at 4:00 p.m. (EET)
Vaisala Corporation: Managers’ Transactions – Castrén, Petri
____________________________________________
Person subject to the notification requirement
Name: Castrén, Petri
Position: Member of the Board/Deputy member
Issuer: Vaisala Oyj
LEI: 743700RNDD7KU11HW873
Notification type: INITIAL NOTIFICATION
Reference number: 97301/5/4
____________________________________________
Transaction date: 2025-02-20
Venue: NASDAQ HELSINKI LTD (XHEL)
Instrument type: SHARE
ISIN: FI0009900682
Nature of the transaction: DISPOSAL
Transaction details
(1): Volume: 216 Unit price: 52 EUR
(2): Volume: 284 Unit price: 52 EUR
(3): Volume: 935 Unit price: 51.4 EUR
(4): Volume: 2 Unit price: 51.4 EUR
(5): Volume: 63 Unit price: 51.4 EUR
Aggregated transactions
(5): Volume: 1500 Volume weighted average price: 51.6 EUR
More information
Niina Ala-Luopa
+358 400 728 957, ir@vaisala.com
Distribution
Nasdaq Helsinki
Key media
vaisala.com
Vaisala is a global leader in measurement instruments and intelligence for climate action. We equip our customers with devices and data to improve resource efficiency, drive energy transition, and care for the safety and well-being of people and societies worldwide. With almost 90 years of innovation and expertise, we employ a team of close to 2,500 experts committed to taking every measure for the planet. Vaisala series A shares are listed on the Nasdaq Helsinki stock exchange.
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Sanofi - Aventis Groupe22.2.2025 08:30:00 CET | Press release
Press Release: ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease
Teva Pharmaceutical Industries Ltd22.2.2025 08:20:00 CET | Press release
Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn’s Disease
Nokia Oyj21.2.2025 21:30:00 CET | Press release
Nokia Corporation: Repurchase of own shares on 21.02.2025
Sanoma Corp21.2.2025 17:30:00 CET | Press release
SANOMA CORPORATION: ACQUISITION OF OWN SHARES 21 February 2025
Afarak Group SE21.2.2025 17:25:28 CET | Press release
PROFIT WARNING – DECREASE OF TURNOVER AND EBITDA
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom